Contemporary management of acute and chronic deep venous thrombosis

British Medical Bulletin

Volumn 117, Issue 1, 2016, Pages 107-120

  Saha, Prakash ^a   Black, Stephen ^a   Breen, Karen ^b   Patel, Ashish ^a   Modarai, Bijan ^a   Smith, Alberto ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

catheter directed lysis; DVT; endovenous; post Thrombotic syndrome; thrombolysis; venous stent

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K;

ACUTE DISEASE; ANTICOAGULANT THERAPY; BLOOD CLOT LYSIS; CHRONIC DISEASE; COMPRESSION BANDAGE; COMPRESSION STOCKING; COMPRESSION THERAPY; CONSERVATIVE TREATMENT; DEEP VEIN THROMBOSIS; HUMAN; IN-STENT RESTENOSIS; PATIENT SELECTION; POSTTHROMBOSIS SYNDROME; PRIORITY JOURNAL; REVIEW; STENT THROMBOSIS; ULCER; VASCULAR PATENCY; VASCULAR STENT; VEIN BYPASS; VEIN SURGERY; VEIN VALVE; DIAGNOSTIC IMAGING; FIBRINOLYTIC THERAPY; PROCEDURES; STENT; THROMBECTOMY; VENOUS THROMBOSIS;

ACUTE DISEASE; ANTICOAGULANTS; CHRONIC DISEASE; HUMANS; PATIENT SELECTION; STENTS; THROMBECTOMY; THROMBOLYTIC THERAPY; VENOUS THROMBOSIS;

EID: 84960461999     PISSN: 00071420     EISSN: 14718391     Source Type: Journal    
DOI: 10.1093/bmb/ldw006     Document Type: Review

References (82)

1. Cohen AT, Agnelli G, Anderson FA, et al. Venous thromboembolism (VTE) in Europe. The number of VTE events and associated morbidity and mortality. Thromb Haemost 2007;98:756-64.
2. Ashrani AA, Heit JA. Incidence and cost burden of post-Thrombotic syndrome. J Thromb Thrombolysis 2009;28:465-76.
3. Saha P, Humphries J, Modarai B, et al. Leukocytes and the natural history of deep vein thrombosis: current concepts and future directions. Arterioscler Thromb Vasc Biol 2011;31:506-12.
4. Fuchs TA, Brill A, Duerschmied D, et al. Extracellular DNA traps promote thrombosis. Proc Natl Acad Sci USA 2010;107:15880-5.
5. Engelmann B, Massberg S. Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 2013;13:34-45.
6. Modarai B, Burnand KG, Humphries J, et al. The role of neovascularisation in the resolution of venous thrombus. Thromb Haemost 2005;93:801-9.
7. Rose PE. Audit of anticoagulant therapy. J Clin Pathol 1996;49:5-9.
8. Lang KJ, Saha P, Roberts LN, et al. Changing paradigms in the management of deep vein thrombosis. Br J Haematol 2015;170:162-74.
9. Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010;363:2499-510.
10. Schulman S, Kearon C, Kakkar AK, et al. Dabigatran versus warfarin in the treatment of acute venous thromboembolism. N Engl J Med 2009;361:2342-52.
11. Agnelli G, Buller HR, Cohen A, et al. Oral apixaban for the treatment of acute venous thromboembolism. N Engl J Med 2013;369:799-808.
12. Sharma M, Cornelius VR, Patel JP, et al. Efficacy and harms of direct oral anticoagulants in the elderly for stroke prevention in atrial fibrillation and secondary prevention of venous thromboembolism: systematic review and meta-Analysis. Circulation 2015;132:194-204.
13. Schiele F, van Ryn J, Canada K, et al. A specific antidote for dabigatran: functional and structural characterization. Blood 2013;121:3554-62.
14. Mo Y, Yam FK. Recent advances in the development of specific antidotes for target-specific oral anticoagulants. Pharmacotherapy 2015;35:198-207.
15. Yeh CH, Gross PL, Weitz JI. Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood 2014;124:1020-8.
16. Meissner MH, Manzo RA, Bergelin RO, et al. Deep venous insufficiency: The relationship between lysis and subsequent reflux. J Vasc Surg 1993;18:596-605; discussion 6-8.
17. Popuri RK, Vedantham S. The role of thrombolysis in the clinical management of deep vein thrombosis. Arterioscler Thromb Vasc Biol 2011;31:479-84.
18. Okrent D, Messersmith R, Buckman J. Transcatheter fibrinolytic therapy and angioplasty for left iliofemoral venous thrombosis. J Vasc Interv Radiol 1991;2:195-7; discussion 8-200.
19. Watson L, Broderick C, Armon MP. Thrombolysis for acute deep vein thrombosis. Cochr Database Syst Rev 2014;1:CD002783.
20. Baekgaard N, Klitfod L, Broholm R. Safety and efficacy of catheter-directed thrombolysis. Phlebology/Venous Forum R Soc Med 2012;27(Suppl. 1):149-54.
21. Baekgaard N, Broholm R, Just S, et al. Long-Term results using catheter-directed thrombolysis in 103 lower limbs with acute iliofemoral venous thrombosis. Eur J Vasc Endovasc Surg 2010;39:112-7.
22. Sillesen H, Just S, Jorgensen M, et al. Catheter directed thrombolysis for treatment of ilio-femoral deep venous thrombosis is durable, preserves venous valve function and may prevent chronic venous insufficiency. Eur J Vasc Endovasc Surg 2005;30:556-62.
23. Comerota AJ, Aldridge SC, Cohen G, et al. A strategy of aggressive regional therapy for acute iliofemoral venous thrombosis with contemporary venous thrombectomy or catheter-directed thrombolysis. J Vasc Surg 1994;20: 244-54.
24. Schulman S, Beyth RJ, Kearon C, et al. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:257S-98S.
25. Karthikesalingam A, Young EL, Hinchliffe RJ, et al. A systematic review of percutaneous mechanical thrombectomy in the treatment of deep venous thrombosis. Eur J Vasc Endovasc Surg 2011;41:554-65.
26. Francis CW, Blinc A, Lee S, et al. Ultrasound accelerates transport of recombinant tissue plasminogen activator into clots. Ultrasound Med Biol 1995;21:419-24.
27. Engelberger RP, Spirk D, Willenberg T, et al. Ultrasound-Assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis. Circ Cardiovasc Interv 2015;8:e002027.
28. Baekgaard N, Broholm R, Just S. Indications for stenting during thrombolysis. Phlebology/Venous Forum R Soc Med 2013;28(Suppl. 1):112-6.
29. Baekgaard N, Just S, Foegh P. Which criteria demand additive stenting during catheter-directed thrombolysis? Phlebology/Venous Forum R Soc Med 2014;29:112-8.
30. OSullivan GJ, Sheehan J, Lohan D, et al. Iliofemoral venous stenting extending into the femoral region: initial clinical experience with the purpose-designed Zilver Vena stent. J Cardiovasc Surg 2013;54:255-61.
31. de Wolf MA, de Graaf R, Kurstjens RL, et al. Short-Term clinical experience with a dedicated venous nitinol stent: initial results with the sinus-venous stent. Eur J Vasc Endovasc Surg 2015;50:518-26.
32. Sharifi M, Bay C, Mehdipour M, et al. Thrombus Obliteration by Rapid Percutaneous Endovenous Intervention in Deep Venous Occlusion (TORPEDO) trial: midterm results. J Endovasc Ther 2012;19:273-80.
33. Enden T, Sandset PM, Klow NE. Evidence-based practice for patients with severe venous thrombosis. Tidsskrift for Den Norske Laegeforening: Tidsskrift for Praktisk Medicin, ny Raekke 2012;132:1215-6.
34. Vedantham S, Goldhaber SZ, Kahn SR, et al. Rationale and design of the ATTRACT Study: A multicenter randomized trial to evaluate pharmacomechanical catheter-directed thrombolysis for the prevention of postthrombotic syndrome in patients with proximal deep vein thrombosis. Am Heart J 2013;165:523-30 e3.
35. Enden T, Haig Y, Klow NE, et al. Long-Term outcome after additional catheter-directed thrombolysis versus standard treatment for acute iliofemoral deep vein thrombosis (the CaVenT study): A randomised controlled trial. Lancet 2012;379:31-8.
36. Arnoldussen CW, Wittens CH. An imaging approach to deep vein thrombosis and the lower extremity thrombosis classification. Phlebology/Venous Forum R Soc Med 2012;27(Suppl. 1):143-8.
37. Strijkers RH, Arnoldussen CW, Wittens CH. Validation of the LET classification. Phlebology/Venous Forum R Soc Med 2015;30:14-9.
38. Jayaraj A, Meissner MH. A comparison of Villalta-Prandoni scale and venous clinical severity score in the assessment of post thrombotic syndrome. Ann Vasc Surg 2014;28:313-7.
39. Saunders JH, Arya PH, Abisi S, et al. Catheter-directed thrombolysis for iliofemoral deep vein thrombosis. Br J Surg 2013;100:1025-9.
40. AndiaME, Saha P, Jenkins J, et al. Fibrin-Targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. Arterioscler Thromb Vasc Biol 2014;34:1193-8.
41. Saha P, Andia ME, Modarai B, et al. Magnetic resonance T1 relaxation time of venous thrombus is determined by iron processing and predicts susceptibility to lysis. Circulation 2013;128:729-36.
42. Phinikaridou A, Andia ME, Saha P, et al. In vivo magnetization transfer and diffusion-weighted magnetic resonance imaging detects thrombus composition in a mouse model of deep vein thrombosis. Circ Cardiovasc Imaging 2013;6:433-40.
43. Kahn SR. How I treat postthrombotic syndrome. Blood 2009;114:4624-31.
44. Ziegler S, Schillinger M, Maca TH, et al. Post-Thrombotic syndrome after primary event of deep venous thrombosis 10 to 20 years ago. Thromb Res 2001;101:23-33.
45. Beckman MG, Hooper WC, Critchley SE, et al. Venous thromboembolism: A public health concern. Am J Prev Med 2010;38:S495-501.
46. Phillips T, Stanton B, Provan A, et al. A study of the impact of leg ulcers on quality of life: financial, social, and psychologic implications. J Am Acad Dermatol 1994;31:49-53.
47. O'Donnell TF Jr, Browse NL, Burnand KG, et al. The socioeconomic effects of an iliofemoral venous thrombosis. J Surg Res 1977;22:483-8.
48. Couzan S, Leizorovicz A, Laporte S, et al. A randomized double-blind trial of upward progressive versus degressive compressive stockings in patients with moderate to severe chronic venous insufficiency. J Vasc Surg 2012;56: 1344-50 e1.
49. Kahn SR, Shapiro S, Wells PS, et al. Compression stockings to prevent post-Thrombotic syndrome: A randomised placebo-controlled trial. Lancet 2014;383:880-8.
50. OMeara S, Cullum N, Nelson EA, et al. Compression for venous leg ulcers. Cochr Database Syst Rev 2012;11: CD000265.
51. Gohel MS, Barwell JR, Taylor M, et al. Long term results of compression therapy alone versus compression plus surgery in chronic venous ulceration (ESCHAR): randomised controlled trial. BMJ 2007;335:83.
52. OMeara S, Martyn-St James M. Foam dressings for venous leg ulcers. Cochr Database Syst Rev 2013;5: CD009907.
53. OMeara S, Martyn-St James M. Alginate dressings for venous leg ulcers. Cochr Database Syst Rev 2013;4: CD010182.
54. OMeara S, Al-Kurdi D, Ologun Y, et al. Antibiotics and antiseptics for venous leg ulcers. Cochr Database Syst Rev 2010;CD003557.
55. Stacey MC, Jopp-Mckay AG, Rashid P, et al. The influence of dressings on venous ulcer healing-A randomised trial. Eur J Vasc Endovasc Surg 1997;13:174-9.
56. Martinez MJ, Bonfill X, Moreno RM, et al. Phlebotonics for venous insufficiency. Cochr Database Syst Rev 2005; CD003229.
57. Danielsson G, Jungbeck C, Peterson K, et al. A randomised controlled trial of micronised purified flavonoid fraction vs placebo in patients with chronic venous disease. Eur J Vasc Endovasc Surg 2002;23: 73-6.
58. Rabe E, Jaeger KA, Bulitta M, et al. Calcium dobesilate in patients suffering from chronic venous insufficiency: A double-blind, placebo-controlled, clinical trial. Phlebology/Venous Forum R Soc Med 2011;26:162-8.
59. Rabe E, Stucker M, Esperester A, et al. Efficacy and tolerability of a red-vine-leaf extract in patients suffering from chronic venous insufficiency-results of a double-blind placebo-controlled study. Eur J Vasc Endovasc Surg 2011;41:540-7.
60. Wittens C, Davies AH, Baekgaard N, et al. Editors Choice-management of chronic venous disease: clinical practice guidelines of the european society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 2015;49: 678-737.
61. Alhadad A, Kolbel T, Herbst A, et al. Iliocaval vein stenting: long term survey of postthrombotic symptoms and working capacity. J Thromb Thrombolysis 2011;31: 211-6.
62. de Graaf R, Arnoldussen C, Wittens CH. Stenting for chronic venous obstructions a new era. Phlebology/Venous Forum R Soc Med 2013;28(Suppl. 1):117-22.
63. Hartung O, Loundou AD, Barthelemy P, et al. Endovascular management of chronic disabling ilio-caval obstructive lesions: long-Term results. Eur J Vasc Endovasc Surg 2009;38:118-24.
64. Kurklinsky AK, Bjarnason H, Friese JL, et al. Outcomes of venoplasty with stent placement for chronic thrombosis of the iliac and femoral veins: single-center experience. J Vasc Interv Radiol 2012;23:1009-15.
65. Lou WS, Gu JP, He X, et al. Endovascular treatment for iliac vein compression syndrome: A comparison between the presence and absence of secondary thrombosis. Korean J Radiol 2009;10:135-43.
66. Meng QY, Li XQ, Qian AM, et al. Endovascular treatment of iliac vein compression syndrome. Chin Med J 2011;124:3281-4.
67. Nayak L, Hildebolt CF, Vedantham S. Postthrombotic syndrome: feasibility of a strategy of imaging-guided endovascular intervention. J Vasc Interv Radiol 2012; 23:1165-73.
68. Nazarian GK, Austin WR, Wegryn SA, et al. Venous recanalization by metallic stents after failure of balloon angioplasty or surgery: four-year experience. Cardiovasc Intervent Radiol 1996;19:227-33.
69. Neglen P, Hollis KC, Olivier J, et al. Stenting of the venous outflow in chronic venous disease: long-Term stent-related outcome, clinical, and hemodynamic result. J Vasc Surg 2007;46:979-90.
70. OSullivan GJ, Semba CP, Bittner CA, et al. Endovascular management of iliac vein compression (May-Thurner) syndrome. J Vasc Interv Radiol 2000;11:823-36.
71. Oguzkurt L, Ozkan U, Ulusan S, et al. Compression of the left common iliac vein in asymptomatic subjects and patients with left iliofemoral deep vein thrombosis. J Vasc Interv Radiol 2008;19:366-70; quiz 71.
72. Oguzkurt L, Tercan F, Ozkan U, et al. Iliac vein compression syndrome: outcome of endovascular treatment with long-Term follow-up. Eur J Radiol 2008;68:487-92.
73. Raju S, Hollis K, Neglen P. Obstructive lesions of the inferior vena cava: clinical features and endovenous treatment. J Vasc Surg 2006;44:820-7.
74. Rosales A, Sandbaek G, Jorgensen JJ. Stenting for chronic post-Thrombotic vena cava and iliofemoral venous occlusions: mid-Term patency and clinical outcome. Eur J Vasc Endovasc Surg 2010;40:234-40.
75. Titus JM, Moise MA, Bena J, et al. Iliofemoral stenting for venous occlusive disease. J Vasc Surg 2011;53: 706-12.
76. Ye K, Lu X, Li W, et al. Long-Term outcomes of stent placement for symptomatic nonthrombotic iliac vein compression lesions in chronic venous disease. J Vasc Interv Radiol 2012;23:497-502.
77. Gloviczki P, Kalra M, Duncan AA, et al. Open and hybrid deep vein reconstructions: To do or not to do? Phlebology/Venous Forum R Soc Med 2012;27(Suppl. 1): 103-6.
78. Garg N, Gloviczki P, Karimi KM, et al. Factors affecting outcome of open and hybrid reconstructions for nonmalignant obstruction of iliofemoral veins and inferior vena cava. J Vasc Surg 2011;53:383-93.
79. Masuda EM, Kistner RL. Long-Term results of venous valve reconstruction: A four-To twenty-one-year follow-up. J Vasc Surg 1994;19:391-403.
80. Pavcnik D, Uchida B, Kaufman J, et al. Percutaneous management of chronic deep venous reflux: review of experimental work and early clinical experience with bioprosthetic valve. Vasc Med 2008;13:75-84.
81. Rosales A. Valve reconstructions. Phlebology/Venous Forum R Soc Med 2015;30:50-8.
82. Bazigou E, Lyons OT, Smith A, et al. Genes regulating lymphangiogenesis control venous valve formation and maintenance in mice. J Clin Invest 2011;121:2984-92.